Arch Biopartners Inc. ACHFF
Set alert
0.57 USD -0.02 -2.56%
As of Nov 2, 3:58 PM ET
0.57 Day range 0.58
0.288 52-week range 1.02
- YTD
- -35.45%
- 1 year
- -19.49%
- Open
- 0.58
- Prev close
- 0.585
- Mkt cap
- 38.72M
- Vol
- 3.00K
- Avg vol
- 19.95K
- EPS
- -0.04
- P/E
- 0.00
More statistics
- Low
- 0.57
- High
- 0.58
- Earnings
- Jan 29, 2024
6M chart
Signals (19)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 23, 2026 | 1 week ago |
| SMA: Bullish | Oct 20, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 13, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 9, 2026 | 3 weeks ago |
| MACD: Buy Signal | Oct 6, 2026 | 4 weeks ago |
| SMA: Bearish | Sep 10, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 25, 2026 | 2 months ago |
| RSI: Overbought | Aug 14, 2026 | 2 months ago |
| RSI: Overbought | Aug 10, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 7, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 7, 2026 | 3 months ago |
| RSI: Overbought | Jun 26, 2026 | 4 months ago |
| SMA: Bullish | Jun 18, 2026 | 4 months ago |
| RSI: Overbought | Jun 18, 2026 | 4 months ago |
| SMA: Bullish | Jun 12, 2026 | 4 months ago |
| SMA: Bearish | Jun 9, 2026 | 4 months ago |
| SMA: Bullish | Jun 4, 2026 | 5 months ago |
| SMA: Bearish | Jun 3, 2026 | 5 months ago |
| SMA: Bullish | Jun 1, 2026 | 5 months ago |
Financial health
Altman Z-Score
-1106.57 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -54.3×
FY 2016 5y median -54.3× FY 2025
P/S 0.0×
FY 2016 5y median 34.6× FY 2025
P/B -21.7×
FY 2016 5y median -25.6× FY 2025
P/FCF -53.2×
FY 2016 5y median -47.8× FY 2025
EV/EBITDA -67.4×
FY 2016 5y median -25.2× FY 2025
EV/Sales 0.0×
FY 2016 5y median 36.7× FY 2025
FCF Yield -1.9%
FY 2016 5y median -1.9% FY 2025
Profitability
Gross Margin 0.0%
FY 2016 5y median -6.5% FY 2025
Operating Margin 0.0%
FY 2016 5y median -144.0% FY 2025
Net Margin 0.0%
FY 2016 5y median -146.0% FY 2025
ROE 40.0%
FY 2016 5y median 40.0% FY 2025
ROIC 144.5%
FY 2016 5y median 250.2% FY 2025
ROA -1485.5%
FY 2016 5y median -284.1% FY 2025
Growth (YoY)
Revenue -100.0%
FY 2016 FY 2025
Operating Income 62.0%
FY 2016 FY 2025
EPS (diluted) 61.7%
FY 2016 FY 2025
Free Cash Flow 32.0%
FY 2016 FY 2025
Financial Health
Current Ratio 0.0×
FY 2016 5y median 0.2× FY 2025
Quick Ratio 0.0×
FY 2016 5y median 0.2× FY 2025
Debt / Equity -0.7×
FY 2016 5y median -0.9× FY 2025
Net Debt / EBITDA -2.2×
FY 2016 5y median -1.4× FY 2025
Interest Coverage -5.8×
FY 2016 5y median -5.8× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-09-30
